Financials
- Market Capitalization 217.46 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.08
市销率
0.69
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3557 | CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 2.17 USD | +0.93% | +1.40% | +68.22% | +92.04% | 217.56 M USD | ||
| 3563 | DERM Journey Medical Corporation - Common Stock | 7.78 USD | +2.77% | +3.18% | +22.14% | +10.35% | 219.59 M USD | ||
| 3684 | LFCR Lifecore Biomedical, Inc. - Common Stock | 4.74 USD | +7.97% | +1.94% | +5.33% | -36.03% | 179.42 M USD | ||
| 3718 | OGI Organigram Global Inc. - Common Shares | 1.20 USD | +1.69% | -4.76% | +29.03% | -15.79% | 161.35 M USD |